Kimberly-Clark Corporation (NYSE: KMB) today announced that Joseph Romanelli, president of Human Health International for Merck & Co., Inc., Rahway, NJ, USA, ("MSD") has been elected to its board...

Kimberly-Clark (NYSE: KMB) will issue its third quarter 2024 results on Tuesday, October 22. A press release and supplemental materials will be issued at approximately 6:35 a.m. EDT....

The board of directors of Kimberly-Clark Corporation (NYSE: KMB) has declared a regular quarterly dividend of $1.22 per share. The dividend is payable in cash on October 2, 2024, to stockholders...

Delivers net sales of $5.0 billion driven by 4 percent organic sales growth Strong EPS expansion driven by innovation-led volume gains, effective cost management and productivity Company increases...

Kimberly-Clark (NYSE: KMB) today announced that Craig Slavtcheff has been appointed Chief Research and Development Officer, effective July 29. Slavtcheff will succeed Robert Long, who is retiring...